Outro

In this episode, Christina Farr sits down with Othman Laraki, co-founder and CEO of Color. They discuss the "tortuous" yet rewarding journey of building a generational healthcare company. Othman shares how Color successfully navigated three major pivots—evolving from a cancer genetics startup into a national COVID-19 infrastructure provider, and finally into a comprehensive virtual cancer clinic. They explore the critical differences between tech and healthcare, the evolution of risk in venture capital, and why long-term success in the industry requires a deep commitment to solving complex clinical problems. Check out the Granola Notes from this episode here: ⁠https://notes.granola.ai/t/d1e8a189-ddb1-4c4f-b92d-3d4d509e4937-008umkv4⁠. 
—
SPONSOR: Granola
Granola AI, The AI notepad for people in back-to-back meetings: granola.ai/lifers with code LIFERS

Interested in sponsoring the show? lifers@a16zstudios.com 
—
LINKS:
Color: https://www.color.com/
Chrissy Farr’s Website: https://www.chrissyfarr.com/ 
Subscribe to the Second Opinion Newsletter: https://secondopinion.media/ 
Chrissy’s Book: The Storyteller's Advantage: https://www.chrissyfarr.com/books 

Lifers with Christina Farr on YouTube: https://www.youtube.com/@LiferswithChristinaFarr 

—
FOLLOW:
Othman:
https://www.linkedin.com/in/othmanlaraki/ 
https://x.com/othman 

Chrissy:
https://www.linkedin.com/in/christinafarr/ 
https://x.com/chrissyfarr 

—
TIMESTAMPS:
(00:00) Preview
(00:58) Intro
(01:21) Lessons from Figma and betting on the tortoise over the hair
(02:45) Othman's transition from Google and Twitter to healthcare founder
(05:07) Why simple features often become massively scalable business engines
(06:52) Analyzing the shift from venture risk-taking to asset management
(10:49) Playing the hard mode of healthcare for long-term impact
(13:10) Why market structure dictates clock speed more than regulation
(15:33) Navigating the conflicting financial incentives of health system CFOs
(15:54) Sponsor: Granola
(16:33) Navigating the conflicting financial incentives of health system CFOs (cont’d)
(17:38) Surviving three pivots by aligning boards and team talent
(20:37) Building infrastructure for the world's largest research study
(23:51) Leaving money on the table to avoid ephemeral COVID traps
(28:00) Launching a national virtual cancer clinic with the ACS
(32:25) Focusing on the five high-spend pillars of patient identity
(34:58) Closing the gap between clinical guidelines and early-stage screening
(36:16) Removing friction to increase cancer screening rates by seventy percent
(40:25) Mastering the diverse unit economics of different payer books
(42:29) Preserving the nimbleness of private companies over going public
(43:40) Wrap